Results for "Dasatinib Quercetin"

5 articles

Rewriting the Code: Advanced Stem Cell Rejuvenation Strategies
Regenerative Medicine
Premium

Rewriting the Code: Advanced Stem Cell Rejuvenation Strategies

Dive deep into partial reprogramming, niche remodeling, senolytics, and cutting-edge clinical therapies — the molecular toolkit for reversing stem cell aging.

TutorialAdvanced
May 2, 2026 0
Reprogramming the Aged Immune System: Senolytics, Cytokine Blockade, and Epigenetic Rejuvenation
Autoimmune & Arthritis
Premium

Reprogramming the Aged Immune System: Senolytics, Cytokine Blockade, and Epigenetic Rejuvenation

A mechanistic deep-dive into cutting-edge anti-inflammaging interventions — from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.

TutorialAdvanced
May 2, 2026 0
Vascular Rejuvenation: Advanced Interventions to Reverse Arterial Aging
Heart Health
Premium

Vascular Rejuvenation: Advanced Interventions to Reverse Arterial Aging

Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions — from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches — that are redefining what's possible in cardiovascular longevity.

TutorialAdvanced
May 2, 2026 0
ECM Remodeling: Therapeutic Frontiers and Precision Interventions
Regenerative Medicine
Premium

ECM Remodeling: Therapeutic Frontiers and Precision Interventions

Master the cutting-edge molecular targets, clinical trial data, and emerging therapeutic strategies aimed at reversing ECM aging — from senolytic combinations to biomaterial scaffolds and epigenetic reprogramming.

TutorialAdvanced
May 1, 2026 0
p16/p21-SASP Pathways: Molecular Targets for Senolytic Drug Development
Regenerative Medicine
Premium

p16/p21-SASP Pathways: Molecular Targets for Senolytic Drug Development

Explore the molecular mechanisms of cellular senescence and how p16/p21 pathways drive SASP production, plus cutting-edge senolytic drug targets.

TutorialAdvanced
Apr 14, 2026 0